Related Experiment Video
Updated: Aug 18, 2026

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
Regulation of macrophage phagocytosis of apoptotic cells by cAMP
A G Rossi1, J C McCutcheon, N Roy
1Department of Medicine (RIE), Rayne Laboratory, The University of Edinburgh Medical School, Scotland, UK. a.g.rossi@ed.ac.uk
Abstract:
Regulation of macrophage capacity to remove apoptotic cells may control the balance of apoptotic and necrotic leukocytes at inflamed foci and the extent of leukocyte-mediated tissue damage. Although the molecules involved in the phagocytic process are beginning to be defined, little is known about the underlying regulatory and signaling mechanisms controlling this process. In this paper, we have investigated the effects of treatment of human monocyte-derived macrophages with PGs and other agents that elevate intracellular cAMP on phagocytosis. PGE2 and PGD2 specifically reduced the proportion of macrophages that phagocytosed apoptotic cells. Similar results were obtained with the membrane-permeable cAMP analogues dibutyryl-cAMP and 8-bromo-cAMP but not with the cGMP analogue dibutyryl-GMP. Consistent with the observation that phagocytosis was inhibited by cAMP elevation, treatment of monocyte-derived macrophages with PGE2 resulted in rapid, transient increase in levels of intracellular cAMP. These effects were not due to nonspecific inhibition of monocyte-derived macrophage phagocytosis given that ingestion of Ig-opsonized erythrocytes was unaffected. Elevation of cAMP induced morphologic alterations indicative of changes in the adhesive status of the macrophage, including cell rounding and disassembly of structures that represent points of contact with substrate containing actin and talin. These results strongly suggest that rapid activation of cAMP signaling pathways by inflammatory mediators regulates processes that limit tissue injury and that modulation of cAMP levels represents an additional therapeutic target in the control of resolution of inflammation.
Insights
Prostaglandins E2 and D2, which increase cyclic AMP (cAMP) levels, reduce macrophage phagocytosis of apoptotic cells. This suggests cAMP signaling regulates inflammation resolution and offers a therapeutic target.
Area of Science:
- Immunology
- Cell Biology
- Biochemistry
Background:
- Macrophage phagocytosis of apoptotic cells is crucial for resolving inflammation and preventing tissue damage.
- The regulatory and signaling mechanisms controlling this phagocytic process are not well understood.
Purpose of the Study:
- To investigate the effects of prostaglandins (PGs) and agents that elevate intracellular cyclic adenosine monophosphate (cAMP) on the phagocytic capacity of human monocyte-derived macrophages.
- To explore the role of cAMP signaling pathways in regulating macrophage-mediated clearance of apoptotic cells.
Main Methods:
- Human monocyte-derived macrophages were treated with PGE2, PGD2, cAMP analogues (dibutyryl-cAMP, 8-bromo-cAMP), and a cGMP analogue (dibutyryl-GMP).
- Phagocytosis of apoptotic cells and Ig-opsonized erythrocytes was assessed.
- Intracellular cAMP levels and macrophage morphology were analyzed following PGE2 treatment.
Main Results:
- PGE2 and PGD2 significantly reduced the proportion of macrophages phagocytosing apoptotic cells.
- Elevating intracellular cAMP with analogues mimicked this inhibitory effect, while cGMP analogues had no impact.
- PGE2 treatment led to a rapid, transient increase in intracellular cAMP levels.
- Macrophage phagocytosis of Ig-opsonized erythrocytes remained unaffected, indicating specificity.
- cAMP elevation induced changes in macrophage morphology, suggesting altered adhesive properties.
Conclusions:
- Activation of cAMP signaling pathways by inflammatory mediators like PGs regulates macrophage phagocytosis of apoptotic cells.
- This regulation plays a role in limiting tissue injury during inflammation.
- Modulation of cAMP levels presents a potential therapeutic strategy for controlling inflammation resolution.
Related Concept Videos
Apoptosis
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Cellular Injury V: Apoptosis and Autophagy

